It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
DVHGF’s FA Score shows that 1 FA rating(s) are green whileLSBCF’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
DVHGF’s TA Score shows that 1 TA indicator(s) are bullish while LSBCF’s TA Score has 6 bullish TA indicator(s).
DVHGF (@Biotechnology) experienced а 0.00% price change this week, while LSBCF (@Biotechnology) price change was +3.84% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was +1.51%. For the same industry, the average monthly price growth was -3.12%, and the average quarterly price growth was +61.90%.
Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
| DVHGF | LSBCF | DVHGF / LSBCF | |
| Capitalization | 10.5M | 34.2M | 31% |
| EBITDA | -3.26M | N/A | - |
| Gain YTD | -46.340 | -75.384 | 61% |
| P/E Ratio | N/A | N/A | - |
| Revenue | 31M | N/A | - |
| Total Cash | 9.76M | N/A | - |
| Total Debt | 137K | N/A | - |
| DVHGF | LSBCF | |
|---|---|---|
| RSI ODDS (%) | N/A | N/A |
| Stochastic ODDS (%) | N/A | 2 days ago 47% |
| Momentum ODDS (%) | N/A | 2 days ago 60% |
| MACD ODDS (%) | 4 days ago 13% | 2 days ago 67% |
| TrendWeek ODDS (%) | 2 days ago 20% | 2 days ago 55% |
| TrendMonth ODDS (%) | 2 days ago 17% | 2 days ago 50% |
| Advances ODDS (%) | N/A | 4 days ago 73% |
| Declines ODDS (%) | N/A | 17 days ago 88% |
| BollingerBands ODDS (%) | N/A | 2 days ago 67% |
| Aroon ODDS (%) | 2 days ago 8% | N/A |
A.I.dvisor indicates that over the last year, DVHGF has been loosely correlated with CSPHF. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if DVHGF jumps, then CSPHF could also see price increases.
| Ticker / NAME | Correlation To DVHGF | 1D Price Change % | ||
|---|---|---|---|---|
| DVHGF | 100% | N/A | ||
| CSPHF - DVHGF | 38% Loosely correlated | N/A | ||
| JAGX - DVHGF | 27% Poorly correlated | +0.57% | ||
| RNAZ - DVHGF | 25% Poorly correlated | -2.87% | ||
| HMTXF - DVHGF | 21% Poorly correlated | N/A | ||
| LSBCF - DVHGF | 3% Poorly correlated | +2.36% | ||
More | ||||
A.I.dvisor indicates that over the last year, LSBCF has been loosely correlated with STTK. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if LSBCF jumps, then STTK could also see price increases.
| Ticker / NAME | Correlation To LSBCF | 1D Price Change % | ||
|---|---|---|---|---|
| LSBCF | 100% | +2.36% | ||
| STTK - LSBCF | 38% Loosely correlated | -3.03% | ||
| BCTX - LSBCF | 30% Poorly correlated | -4.08% | ||
| GLTO - LSBCF | 27% Poorly correlated | +0.08% | ||
| PROK - LSBCF | 26% Poorly correlated | -4.29% | ||
| GNFT - LSBCF | 23% Poorly correlated | +6.77% | ||
More | ||||